Lyell Immunopharma, Inc.
Hedge Funds Holdings
Last updated:
Lyell Immunopharma, Inc.‘s stocks are currently a part of 59 hedge funds’ portfolios, which represents 16.8% of the total amount of its stocks outstanding. This makes up a total of 41.50M shares of Lyell Immunopharma, Inc.. Compared to the previous quarter, the number fell by -64.40% or -75.10M shares fewer. As for the holding position changes, 28.81% (17) of current hedge fund investors increased the number of shares held, 25.42% (15) of current holders sold a part of the shares held, and 11.86% (7) closed the holdings completely. 11 hedge funds are new holders of Lyell Immunopharma, Inc. stock in Q1 2023, it is 18.64% of total holders.
Hedge funds holding Lyell Immunopharma (Q2 2021 – Q1 2023)
| Q2 2021 | 52 |
|---|---|
| Q3 2021 | 62 |
| Q4 2021 | 76 |
| Q1 2022 | 77 |
| Q2 2022 | 71 |
| Q3 2022 | 86 |
| Q4 2022 | 92 |
| Q1 2023 | 59 |
Hedge funds changes in Lyell Immunopharma positions (Q2 2021 – Q1 2023)
| Q2 2021 | 52 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2021 | 28 | 11 | 11 | 18 | -6 |
| Q4 2021 | 26 | 27 | 10 | 11 | 2 |
| Q1 2022 | 16 | 35 | 10 | 15 | 1 |
| Q2 2022 | 11 | 26 | 19 | 15 | 0 |
| Q3 2022 | 21 | 34 | 13 | 6 | 12 |
| Q4 2022 | 16 | 33 | 18 | 9 | 16 |
| Q1 2023 | 11 | 17 | 15 | 7 | 9 |
Hedge funds changes in Lyell Immunopharma stock options (Q2 2021 – Q1 2023)
| Q2 2021 | 0 | 0 |
|---|---|---|
| Q3 2021 | 0 | 0 |
| Q4 2021 | 0 | 148,000 |
| Q1 2022 | 3,046,000 | 92,000 |
| Q2 2022 | 3,924,000 | 45,000 |
| Q3 2022 | 15,000 | 0 |
| Q4 2022 | 48,416 | 6,940 |
| Q1 2023 | 0 | 0 |